Authors: RAMIREZ AJ TOWLSON KE LEANING MS RICHARDS MA RUBENS RD

Citation: Aj. Ramirez et al., DO PATIENTS WITH ADVANCED BREAST-CANCER BENEFIT FROM CHEMOTHERAPY, British Journal of Cancer, 78(11), 1998, pp. 1488-1494

Authors: MILES DW TOWLSON KE GRAHAM R REDDISH M LONGENECKER BM TAYLORPAPADIMITRIOU J RUBENS RD

Citation: Dw. Miles et al., A RANDOMIZED PHASE-II STUDY OF SIALYL-TN AND DETOX-B ADJUVANT WITH ORWITHOUT CYCLOPHOSPHAMIDE PRETREATMENT FOR THE ACTIVE SPECIFIC IMMUNOTHERAPY OF BREAST-CANCER, British Journal of Cancer, 74(8), 1996, pp. 1292-1296

Authors: TWELVES CJ DOBBS NA LAWRENCE MA RAMIREZ AJ SUMMERHAYES M RICHARDS MA TOWLSON KE RUBENS RD

Citation: Cj. Twelves et al., IODODOXORUBICIN IN ADVANCED BREAST-CANCER - A PHASE-II EVALUATION OF CLINICAL ACTIVITY, PHARMACOLOGY AND QUALITY-OF-LIFE, British Journal of Cancer, 69(4), 1994, pp. 726-731

Authors: DOBBS NA TWELVES CJ RAMIREZ AJ TOWLSON KE GREGORY WM RICHARDS MA

Citation: Na. Dobbs et al., PATIENT ACCEPTABILITY AND PRACTICAL IMPLICATIONS OF PHARMACOKINETIC STUDIES IN PATIENTS WITH ADVANCED CANCER, European journal of cancer, 29A(12), 1993, pp. 1707-1711